12/4
04:36 pm
advm
Form 8-K Adverum Biotechnologies, For: Dec 04
Low
Report
Form 8-K Adverum Biotechnologies, For: Dec 04
12/3
09:42 pm
advm
Form 4 Adverum Biotechnologies, For: Dec 01 Filed by: Leonard Braden Michael
Low
Report
Form 4 Adverum Biotechnologies, For: Dec 01 Filed by: Leonard Braden Michael
12/1
07:15 am
advm
Form SC 14D9/A Adverum Biotechnologies, Filed by: Adverum Biotechnologies, Inc.
Low
Report
Form SC 14D9/A Adverum Biotechnologies, Filed by: Adverum Biotechnologies, Inc.
11/28
03:26 pm
advm
Form SCHEDULE 13G/A Adverum Biotechnologies, Filed by: Frazier Life Sciences Public Fund, L.P.
Neutral
Report
Form SCHEDULE 13G/A Adverum Biotechnologies, Filed by: Frazier Life Sciences Public Fund, L.P.
11/21
04:02 pm
advm
Form 8-K Adverum Biotechnologies, For: Nov 19
Low
Report
Form 8-K Adverum Biotechnologies, For: Nov 19
11/12
04:09 pm
advm
Form 10-Q Adverum Biotechnologies, For: Sep 30
Low
Report
Form 10-Q Adverum Biotechnologies, For: Sep 30
11/10
12:32 pm
advm
Form SCHEDULE 13D/A Adverum Biotechnologies, Filed by: BML Investment Partners, L.P.
Low
Report
Form SCHEDULE 13D/A Adverum Biotechnologies, Filed by: BML Investment Partners, L.P.
11/7
05:23 pm
advm
Form SC 14D9 Adverum Biotechnologies, Filed by: Adverum Biotechnologies, Inc.
Low
Report
Form SC 14D9 Adverum Biotechnologies, Filed by: Adverum Biotechnologies, Inc.
11/7
04:08 pm
advm
Form SC TO-T Adverum Biotechnologies, Filed by: ELI LILLY & Co
Low
Report
Form SC TO-T Adverum Biotechnologies, Filed by: ELI LILLY & Co
10/24
04:30 pm
advm
Form SC TO-C Adverum Biotechnologies, Filed by: ELI LILLY & Co
Low
Report
Form SC TO-C Adverum Biotechnologies, Filed by: ELI LILLY & Co
10/24
09:27 am
advm
Form SC14D9C Adverum Biotechnologies, Filed by: Adverum Biotechnologies, Inc.
Medium
Report
Form SC14D9C Adverum Biotechnologies, Filed by: Adverum Biotechnologies, Inc.
10/24
09:20 am
advm
Form 8-K Adverum Biotechnologies, For: Oct 24
Medium
Report
Form 8-K Adverum Biotechnologies, For: Oct 24
9/22
08:11 am
advm
Form 8-K Adverum Biotechnologies, For: Sep 22
High
Report
Form 8-K Adverum Biotechnologies, For: Sep 22